Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

More cardiology groups step forward with concerns about Medicare payment cuts

The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Heart specialists receive nearly $30M to study PCI and CABG among underrepresented patient groups

Teams from the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine will collaborate on the research.

Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices.

Heart failure symptoms after PCI increase risk of adverse events

Researchers in Japan tracked BNP levels and bleeding events among more than 7,000 PCI patients. The group noted that managing heart failure in the first 30 days after PCI can help boost outcomes.

Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.

TAVR vs. surgery: Exploring 5-year outcomes among intermediate-risk patients

A group of renowned TAVR specialists examined data from 783 pairs of intermediate-risk patients, sharing their findings in the Journal of the American College of Cardiology.

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far.

Private equity-backed cardiology group continues busy year with acquisition of Florida practice

Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State.

The Surdonics SurVeil drug-coated balloon to treat peripheral artery disease.

FDA approves next-gen DCB, earning the manufacturer a $27M payment from Abbott

The new-look DCB was designed to provide care with a significantly lower drug load than similar devices.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall